The staphylococcal enterotoxins are the most potent T-cell mitogens known, with staphylococcal enterotoxin A (SEA) capable of stimulating human and mouse T-cell proliferation and induction of the lymphokines interleukin 2 (IL 2) and gamma interferon (IFN8) at concentrations as low as 10-13-10-16 M. IL 2 and IFN8 are biological response modifiers (BRMs) that are being used in experimental cancer therapy. Structure/function studies of the potent enterotoxin effects on lymphocyte function should provide insight into the mechanism of action of these toxins and should also provide an approach for modulation of host defense against cancer. It is proposed that a novel synthetic peptide approach be used to determine the nature of the cellular binding/functional site(s) on staphylococcal enterotoxins. Both SEA and SEB will be studied in receptor competitive binding experiments with synthetic peptides corresponding to enterotoxin sequences that are predicted to appear on the exterior of the molecule. Identification of surface sequences is based primarily on predicted composite surface profiles that are derived from HPLC-derived hydrophilicity, accessibility parameters, and surface B-value parameters of the amino acids of the enterotoxins. In addition to competition studies, labeled peptides will also be tested for binding to receptor. Both monoclonal and polyclonal antibodies to the enterotoxins and the peptides will be tested for blockage of enterotoxin function and binding to receptor. Synthetic peptides will be used to map the epitope specificity of monoclonal antibodies to the enterotoxins that block function and/or receptor binding. Steric relationships of epitopes, and thus various regions of enterotoxin, can be assessed by competitive binding between monoclonal antibodies (and their Fab fragments) of defined epitope specificities with the enterotoxin molecule. Structure/function data on the enterotoxins should help in the construction of agonists and antagonists of enterotoxin action, thereby providing a mechanism for positive or negative regulation of enterotoxin action. Finally, the proposed studies are important because they will provide information on the structural basis of action of the most potent T-cell mitogen and lymphokine inducer known.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI025904-02
Application #
3139578
Study Section
Experimental Immunology Study Section (EI)
Project Start
1988-03-01
Project End
1993-02-28
Budget Start
1989-03-01
Budget End
1990-02-28
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
Schools of Veterinary Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Perrin, G Q; Johnson, H M; Subramaniam, P S (1999) Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle. Blood 93:208-16
Torres, B A; Tanabe, T; Subramaniam, P S et al. (1998) Mechanism of HIV pathogenesis: role of superantigens in disease. Alcohol Clin Exp Res 22:188S-192S
Torres, B A; Johnson, H M (1997) Neuroendocrine peptide hormone regulation of immunity. Chem Immunol 69:155-84
Tanabe, T; Torres, B A; Subramaniam, P S et al. (1997) V beta activation by HIV Nef protein: detection by a simple amplification procedure. Biochem Biophys Res Commun 230:509-13
Soos, J M; Schiffenbauer, J; Torres, B A et al. (1997) Superantigens as virulence factors in autoimmunity and immunodeficiency diseases. Med Hypotheses 48:253-9
Hobeika, A C; Johnson, H M (1996) A neutralizing epitope of the superantigen SEA has agonist activity on T cells. Biochem Biophys Res Commun 223:565-71
Torres, B A; Tanabe, T; Johnson, H M (1996) Characterization of Nef-induced CD4 T cell proliferation. Biochem Biophys Res Commun 225:54-61
Hart, D J; Luo, H; Garry, R F (1996) Biochemical characterization of the reverse transcriptase of a human intracisternal A-type particle (HIAP). AIDS Res Hum Retroviruses 12:1367-72
Johnson, H M; Torres, B A; Soos, J M (1996) Superantigens: structure and relevance to human disease. Proc Soc Exp Biol Med 212:99-109
Torres, B A; Tanabe, T; Johnson, H M (1996) Replication of HIV-1 in human peripheral blood mononuclear cells activated by exogenous Nef. AIDS 10:1042-3

Showing the most recent 10 out of 32 publications